Targovax ASA strengthens management with Lubor Gaal as Chief Financial Officer PR Newswire OSLO, Norway, Feb. 28, 2022 OSLO, Norway, Feb. 28, 2022 /PRNewswire/ -- Targovax ASA (OSE: TRVX) a...
Targovax ASA strengthens management with Lubor Gaal as Chief Financial Officer PR Newswire OSLO, Norway, Feb. 28, 2022 OSLO, Norway, Feb. 28, 2022 /PRNewswire/ -- Targovax ASA (OSE: TRVX) a...
Targovax ASA: Targovax awarded NOK 8.2m grant by Innovation Norway PR Newswire OSLO, Norway, Jan. 12, 2022 OSLO, Norway, Jan. 12, 2022 /PRNewswire/ -- Targovax ASA (OSE: TRVX) a clinical stage...
Targovax ASA: Targovax awarded NOK 8.2m grant by Innovation Norway PR Newswire OSLO, Norway, Jan. 12, 2022 OSLO, Norway, Jan. 12, 2022 /PRNewswire/ -- Targovax ASA (OSE: TRVX) a clinical stage...
Targovax ASA: ONCOS-102 achieves 25.0 months median overall survival in first line mesothelioma PR Newswire OSLO, Norway, Dec. 20, 2021 The median overall survival (mOS) was 25.0 months in the...
Targovax ASA: ONCOS-102 achieves 25.0 months median overall survival in first line mesothelioma The median overall survival (mOS) was 25.0 months in the first-line group of patients treated with...
Targovax ASA: Third quarter 2021 results PR Newswire OSLO, Norway, Nov. 4, 2021 OSLO, Norway, Nov. 4, 2021 /PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage biotechnology company...
Targovax ASA: Third quarter 2021 results PR Newswire OSLO, Norway, Nov. 4, 2021 OSLO, Norway, Nov. 4, 2021 /PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage biotechnology company...
Targovax: Presentation material for today's webcast PR Newswire OSLO, Norway, Oct. 25, 2021 OSLO, Norway, Oct. 25, 2021 /PRNewswire/ -- Targovax will at 14:00 CEST today host a live webcast...
Targovax: Presentation material for today's webcast PR Newswire OSLO, Norway, Oct. 25, 2021 OSLO, Norway, Oct. 25, 2021 /PRNewswire/ -- Targovax will at 14:00 CEST today host a live webcast...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 15.98 | 15.98 | 15.98 | 0 | 0 | DE |
4 | 0 | 0 | 15.98 | 15.98 | 15.98 | 0 | 0 | DE |
12 | 0 | 0 | 15.98 | 15.98 | 15.98 | 0 | 0 | DE |
26 | 0 | 0 | 15.98 | 15.98 | 15.98 | 0 | 0 | DE |
52 | 0 | 0 | 15.98 | 15.98 | 15.98 | 0 | 15.98 | DE |
156 | -463.42 | -96.6666666667 | 479.4 | 479.4 | 15.98 | 1331 | 467.59655824 | DE |
260 | -463.42 | -96.6666666667 | 479.4 | 479.4 | 15.98 | 1576 | 473.42139607 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales